Prostate Biopsies and Surgeries Seen to Fall in US After PSA Screening Found Wanting

Prostate Biopsies and Surgeries Seen to Fall in US After PSA Screening Found Wanting
The number of prostate biopsies and surgeries (radical prostatectomy, or RP) prescribed by doctors to diagnose and treat prostate cancer has dropped significantly since 2012, when a U.S. task force recommended against prostate-specific antigen (PSA) screening for this cancer, according to a study published in JAMA Surgery. The study, “National Trends in Prostate Biopsy and Radical Prostatectomy Volumes Following the United States Preventative Services Task Force Guidelines Against Prostate-Specific Antigen Screening,” is timely, its researchers said, as the task force recommendation is being reconsidered. In the 1990s, the United States implemented several screening programs for prostate cancer, based on the high incidence of this type of cancer and its high potential cure rate when detected in time. But some four years ago, the U.S. Preventative Services Task Force (USPSTF) discouraged PSA screening after a randomized clinical trial showed it of no benefit to mortality rates. PSA-based screening decreased significantly following this recommendation. Few studies since, however, have examined the recommendation's direct impact on diagnostic and therapeutic prostate cancer practices. Researchers analyzed the practice patterns of certifying and recertifying urologists, from 2009 through 2016, looking for changes in the number of prostate biopsies and RP procedures prescribed. The study included a representative sample of urologists across practice settings, and a nationally representative sample of all RP discharges from hospitals. Analysis indicated that, following the USPSTF recommendation, the m
Subscribe or to access all post and page content.

2 comments

  1. The war against PSA is a disgrace. The “Age Weighted” interpretation of the PSA is also an insult to older men. I lost my father to prostate cancer and my brother recovered from Prostate cancer because of the PSA early detection. I have studied this subject for 15 years and find that many Doctors simply do not understand how to use the PSA or ask their patients to come for a second test to establish “doubling time” issues. In addition most Doctors are simply not aware of all the new treatment options other than surgery, radiation and chemo therapy.

    • Tim Bossie says:

      We are sorry for the loss of your father to this cancer. Men, especially doctors, should not discount PSA readings. True, they might not point to cancer, but should you really take a chance? Thank you for the comment and we hope that your brother is still doing well.

Leave a Comment

Your email address will not be published. Required fields are marked *